A randomised phase 2 study of Panitumumab Monotherapy and Panitumumab Plus 5 Fluorouracil as first line therapy for RAS and BRAF wild type metastatic colorectal cancer. MONARCC

Project: Research

Project Description

NHM HREC Ref number: HREC/17/RPAH/365
NMA SSA Ref number: SSA/18/MonH/70
Monash Health Ref: RES-18-0000-078X
SEO Code: 920102 Cancer and Related Disorders
StatusActive
Effective start/end date7/02/1816/10/23